Pharmaceutical
Zejula : Orphan maintenance assessment report (post-authorisation) (II-019)
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Dosage
Zejula : Orphan maintenance assessment report (post-authorisation) (II-019)
Strength
Zejula : Orphan maintenance assessment report (post-authorisation) (II-019)
Pack Size
Zejula : Orphan maintenance assessment report (post-authorisation) (II-019)
Form
Zejula : Orphan maintenance assessment report (post-authorisation) (II-019)
Source
European Medicines Agency
Safety Profile
Contraindications
Zejula : Orphan maintenance assessment report (post-authorisation) (II-019)
Side Effects
Zejula : Orphan maintenance assessment report (post-authorisation) (II-019)
Scan this QR code to access this page quickly on your mobile device.